SeaSpine Announces Preliminary Results for Fourth Quarter

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
54
SeaSpine Announces Preliminary Results for Fourth Quarter and Full-Year 2016

CARLSBAD, Calif., Jan. 09, 2017 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE ), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today preliminary financial results for the fourth quarter and full year 2016. 

Preliminary and unaudited revenue for fourth quarter 2016 is expected to be in the range of $32.5 to $32.7 million, a decrease of approximately 6% compared to the prior year period.  Based on this preliminary estimate, spinal hardware revenue is expected to be approximately $15.9 million and orthobiologics revenue is expected to be approximately $16.7 million. Compared to the fourth quarter of 2015, total U.S. revenue is expected to decrease approximately 4%, to approximately $29.9 million, with both spinal hardware and orthobiologics revenue expected to decrease approximately 4%.

Preliminary and unaudited full year 2016 revenue is expected to be in the range of $128.8 to $129.0 million. Cash and cash equivalents at December 31, 2016 are expected to be approximately $14.6 million and outstanding borrowings under the credit facility are expected to be approximately $3.8 million. 

“During the quarter, we executed on several critical objectives to drive future revenue growth, while exercising solid expense control and cash management. We added several new distributors, continued our focus on surgeon education, and initiated the alpha launches of our Shoreline and Mariner systems, positioning the company well for accelerating sales momentum in 2017,” said Keith Valentine, President and Chief Executive Officer of SeaSpine. “In the year ahead, we plan to further broaden our relationships with high quality distributors, expand our launch of key alpha systems and continue the surgeon-centric product development and innovation that will drive business and improve patient lives.”

The Company expects to issue full-year 2017 revenue and other relevant financial guidance with the release of its final fourth quarter and year-ending 2016 financial results in March.

About SeaSpine SeaSpine is a global medical technology company focused on the design, development and commercialization of surgical solutions for the treatment of patients suffering from spinal disorders. SeaSpine has a comprehensive portfolio of orthobiologics and spinal fusion hardware solutions to meet the varying combinations of products that neurosurgeons and orthopedic spine surgeons need to perform fusion procedures on the lumbar, thoracic and cervical spine. SeaSpine’s orthobiologics products consist of a broad range of advanced and traditional bone graft substitutes and cellular grafts that are designed to improve bone fusion rates following a wide range of orthopedic surgeries, including spine, hip, and extremities procedures. SeaSpine’s spinal fusion hardware portfolio consists of an extensive line of products to facilitate spinal fusion in minimally invasive surgery (MIS), complex spine, deformity and degenerative procedures. Expertise in both orthobiologic sciences and spinal fusion hardware product development allows SeaSpine to offer our surgeon customers a differentiated portfolio and a complete solution to meet their fusion requirements. SeaSpine currently markets its products in the United States and in over 30 countries worldwide.

Forward-Looking Statements SeaSpine cautions you that statements included in this news release that are not a description of historical facts are forward-looking statements that are based on the Company’s current expectations and assumptions. Such forward-looking statements include, but are not limited to, statements relating to the Company’s ability to broaden relationships with distributors, expand the launch of the Shoreline and Mariner systems and continue activities that will drive revenue growth.  In addition, this release contains preliminary financial results for the fourth quarter and full year 2016.  Preliminary results for 2016 are provided prior to completion of all internal and external review and audit procedures and therefore are subject to adjustment.  Among the factors that could cause or contribute to material differences between the Company’s actual results and the expectations indicated by the forward-looking statements are risks and uncertainties that include, but are not limited to: surgeons’ willingness to continue to use the Company’s existing products and to adopt its newly launched products; the ability of newly launched products to perform as designed and to meet clinical needs when implanted in patients; the lack of clinical validation of products in “alpha release” and the fact they may require substantial additional development activities, which could introduce unexpected expense and delay; the Company’s ability to continually develop innovative new and next generation products and product line extensions that satisfy surgeon and patient needs; delays in new and full product launches, including as a result of difficulties in obtaining regulatory clearance; the Company’s ability to attract new, high-quality distributors, whether as a result of inability to reach agreement on financial and other contractual terms or otherwise, disruption to the Company’s existing distribution network as new distributors are added and the ability of new distributors to generate growth or offset disruption to existing distributors; continued pricing pressure, whether as a result of consolidation in hospital systems, competitors or others, as well as exclusion from major healthcare systems, whether as a result of unwillingness to provide required pricing or otherwise; the Company’s ability to invest adequately in the commercialization of its products, and the risk of excess inventory in the event demand for new products is less than the Company’s expectations; the risk of supply shortages, including as a result of the Company’s dependence on a limited number of third-party suppliers for components and raw materials, or otherwise; the Company’s ability to sustain current operations and to continue to invest in product development, sales and marketing initiatives at levels sufficient to drive future revenue growth in light of recent cost-reduction initiatives; unexpected expense, including as a result of developing and launching new and next generation products and product line extensions; the risk that the Company’s products do not demonstrate adequate safety or efficacy, independently or relative to competitive products, to support expected levels of demand or pricing, including in ongoing and future studies, the outcomes of which inherently are uncertain; the Company’s ability to obtain funding on a timely basis on acceptable terms, or at all, to execute its business strategy; general economic and business conditions in the markets in which the Company does business, both in the U.S. and abroad; and other risks and uncertainties more fully described in the Company’s news releases and periodic filings with the Securities and Exchange Commission. The Company’s public filings with the Securities and Exchange Commission are available at www.sec.gov . 

You are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date when made. SeaSpine does not intend to revise or update any forward-looking statement set forth in this news release to reflect events or circumstances arising after the date hereof, except as may be required by law.

Investor Relations Contact Lynn Pieper (415) 513-1281 ir@seaspine.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Loyalty Programs Cut $1500 Annually for Consumers

Updated Category News Views 132

Loyalty Programs: An Essential Tool for Households In a world where every dollar counts, retail loyalty programs have become more than just a marketing strategy—they're lifelines for American households scraping through each month. According to fresh research by the Retail Industry Leaders Association (RILA) and conducted by market research leader Circana, these...

Continue Reading
Zettia R. Barnes: Charting a Path in Home Healthcare

Updated Category News Views 146

The Lifeline of Home Healthcare in DeSoto You know, it ain't every day that someone like Zettia R. Barnes steps up in the realm of home healthcare and makes a mark that genuinely sticks. From rubbing shoulders with patients to steering a whole dang organization like Angels of Hands Home Health Agency Corp., she's got her hands full—and frankly, it’s folks like her who...

Continue Reading
Biotech Hit or Miss: Trials and Tribulations

Updated Category News Views 96

Biotech's Roller Coaster: Triumphs and Setbacks Ah, the biotech sector—it's a bit like jumping on a bull, ain't it? You barely hang on when the beast bucks. Monday's market action was downright wild. The S&P 500 didn't have a party, tumbling 1.92%, and the Nasdaq wasn't any friendlier, plummeting 2.49%. Yet, inside this storm, we see some biotech names either catching...

Continue Reading
Austin Rattler Event Revamps With Two-Day Off-Road Bash

Updated Category News Views 42

Austin's Off-Road Bash Kicks Up Dust in Hill Country It's not just another grind in the biking and running world; the Life Time Austin Rattler's gone off the reservation pushing the pedals and the pace across the rugged terrain of Texas Hill Country. Here's to muscles burning and soles slapping the dirt for two straight days, all in the name of challenging nature's best....

Continue Reading
Exploring Creation: A Fresh Look at Genesis

Updated Category News Views 67

Opening Up Genesis in a New Light Hey, if you’re like most folks, you’ve probably heard Genesis framed as the battleground for science versus religion debates, right? Enter into this mix a fresh take with Robert E. Franzen’s new book, The Narration of Creation. This book asks you to overlook those grand philosophical fights and instead focus on the narrative itself....

Continue Reading
Hermes AI: A New Era in Market Analysis?

Updated Category News Views 111

Revolution or Just Another App? In a world where stock market insights are as cryptic as hieroglyphs to the average Joe, here comes the Hermes AI Analyzer, breaking onto the scene and promising to translate Wall Street's complex lingo into plain, simple language. It's the brainchild of Turkish engineer Umut Tugrul, who has spent decades in the trenches of software...

Continue Reading
Giovanni Recalde Sues County After False Report

Updated Category News Views 153

Justice and Reputation: A Mix-Up Costs Big When the cops screw up, sometimes they really take the cake. That's what Giovanni Recalde learned, the hard way, when his name got tangled in a mess related to a gambling operation he wasn't even a part of. Prince William County police pasted his name into their daily incident report last year like it was no big deal. But it...

Continue Reading
Rakuten Medical Fires Up Phase 1 Trial for RM-0256 Therapy

Updated Category News Views 219

Taking Aim at Refractory Tumors in Japan Get this—Rakuten Medical is stepping into the ring with their new cancer-busting tactic, RM-0256 photoimmunotherapy, right in Japan. We're talking about a Phase 1 trial that'll throw a new kind of punch at solid tumors, specifically targeting troublesome skin cancers that don’t seem to play nice with current treatments. Now,...

Continue Reading
Mars Moves on Cash Tender Offers for Seniors' Notes

Updated Category News Views 197

A Strategic Financial Maneuver or a Casual Gambit? Okay, what’s Mars up to now, you ask? Here we go with this. The behemoth behind some of your favorite snacks and pet indulgences is making waves—not with candy, but with cash. Mars, Incorporated is rolling out tender offers to buy back a substantial chunk of its Senior Notes for $2 billion in cold, hard cash. When a...

Continue Reading
Main Capital Partners Backs TaskRay: Salesforce Expansion

Updated Category News Views 118

Investing in Transformation Main Capital Partners has thrown in with TaskRay, joining hands with Cloud Coach and JustOn to shake up customer delivery on Salesforce. These three are cooking up an ambitious AI-driven platform that's gunning to streamline from project management to financial operations. Main's stepping into this mix with a mindset that aligns with over 800...

Continue Reading

Top 5 Most Recently Viewed Articles

Major Analyst Upgrades: Johnson & Johnson a Key Focus Today

Updated Category News Views 167

Exciting Analyst Upgrades in the Stock Market The stock market is constantly evolving, and today's news shining a spotlight on several major companies is particularly noteworthy. Top Wall Street analysts have made significant changes to their outlooks for various stocks, resulting in several upgrades. Let’s take a closer look at these changes and what they might mean...

Continue Reading
Albany International Corp Facing Legal Scrutiny Over Misstatements

Updated Category News Views 317

Albany International Corp Under Investigation Investors of Albany International Corp. are currently facing significant legal concerns that have given rise to an investigation. This inquiry is primarily centered on potential allegations of misleading statements issued by the company, which may have ultimately led to unexpected financial repercussions. As a well-known...

Continue Reading
Toncoin Experiences Notable Decline of Over 4% Today

Updated Category News Views 131

Toncoin Price Analysis for Recent Days Recently, Toncoin experienced a notable decline, with its price dropping by 4.56% in just 24 hours, settling at $5.42. This downturn is quite different from its strong performance last week, during which Toncoin rose by an impressive 5.0%, increasing from $5.16 to the current price. Recent Price Movements and Volatility A closer look...

Continue Reading
AgriFORCE Unveils Innovative Strategy for Digital Infrastructure Growth

Updated Category News Views 209

Revolutionizing the Digital Landscape: AgriFORCE's Strategy AgriFORCE Growing Systems Ltd. (NASDAQ: AGRI), a key player in the digital infrastructure sector, has recently announced an innovative tri-pillar strategy designed to meet the growing global thirst for computational power. As demands for technology continue to rise, this comprehensive framework focuses on Bitcoin...

Continue Reading
Rethinking Infrastructure Finance: Unlocking Trillions

Updated Category News Views 32

Cracking Open the Infrastructure Conundrum If you think America’s infrastructure is crumbling because of a lack of money, you’re only half right. The real hiccup lies in how we’ve rigged the system to access the cash pile. That’s what Anton Steshenko from the University of Maryland’s Smith School is shouting from the rooftops. According to him, it’s not a...

Continue Reading